Structure of Class B GPCRs: new horizons for drug discovery
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
C lass B GPCRs of the secretin family are important drug targets in many human diseases including diabetes, neurodegeneration, cardiovascular disease and psychiatric disorders. X‐ray crystal structures for the glucagon receptor and corticotropin‐releasing factor receptor 1 have now been published. In this review, we analyse the new structures and how they compare with each other and with C lass A and F receptors. We also consider the differences in druggability and possible similarity in the activation mechanisms. Finally, we discuss the potential for the design of small‐molecule modulators for these important targets in drug discovery. This new structural insight allows, for the first time, structure‐based drug design methods to be applied to C lass B GPCRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009 · cited 1×
“…Weinstein numbering in superscript) (Ballesteros et al., 1995) of the NPxxY motif in TM7 plays an important role during activation, moving into the space created by the shift of TM6 3134 British Journal of Pharmacology (2014) 171 3132–3145 upon G protein binding (Rasmussen et al., 2011).”
BackgroundFredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941 · cited 1×
“The resultant alignments are different from previously proposed sequence alignments of Classes A, B and F (Fredriksson et al., 2003; Bissantz et al., 2004; de Graaf et al., 2011), which were generated without any structural guidance.”
BackgroundCRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Small-molecule agonists for the glucagon-like peptide 1 receptor
Knudsen, L. B., Kiel, D., Teng, M., Behrens, C., Bhumralkar, D., Kodra, J. T., Holst, J. J., Jeppesen, C. B., Johnson, M. D., de Jong, J. C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605701104 · Cited by 232 · cited 2×
“, 2009) that high-throughput screening campaigns (Chen et al., 2007; Knudsen et al., 2007) and homology model-based virtual screening approaches have faced until now (de Graaf et al.”
BackgroundCalcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?
Barwell, J., Gingell, J. J., Watkins, H. A., Archbold, J. K., Poyner, D. R., & Hay, D. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01525.x · Cited by 80
Cited by
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Generic GPCR residue numbers – aligning topology maps while minding the gaps
Isberg, V., de Graaf, C., Bortolato, A., Cherezov, V., Katritch, V., Marshall, F. H., Mordalski, S., Pin, J.-P., Stevens, R. C., Vriend, G., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.001 · Cited by 492
Self-citationThe Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 260
Novel Allosteric Modulators of G Protein-coupled Receptors
Gentry, P. R., Sexton, P. M., & Christopoulos, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.662759 · Cited by 199
“Despite providing new insights into the binding behavior of these NAMs, the inactive and binary complex natures of these structures do not capture the complete structural mechanisms that underlie cooperativity between the allos- AUGUST 7, 2015 • VOLUME 290 • NUMBER 32 JOURNAL OF BIOLOGICAL CHEMISTRY 19483 teric and or…”
BackgroundInfluentialIncretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193
Metadata
- Authors
- Bortolato, A., Doré, A. S., Hollenstein, K., Tehan, B. G., Mason, J. S., & Marshall, F. H.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2014-06-10
- Volume
- 171
- Issue
- 13
- Pages
- 3132-3145
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1484748810
- Cited by
- 117
- References
- 5
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structure of Class B GPCRs: new horizons for drug discovery. https://app.cochat.ai/papers/10.1111/bph.12689
- The paper
- Bortolato, A., Doré, A. S., Hollenstein, K., Tehan, B. G., Mason, J. S., & Marshall, F. H. (2014). Structure of Class B GPCRs: new horizons for drug discovery. British Journal of Pharmacology. https://doi.org/10.1111/bph.12689
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.